It was not until 1997 that Chen, with the help of Andrew Huang, currently president of the Koo Foundation Sun Yat-Sen Cancer Center, obtained grants from Synpac, a UK pharmaceutical company in which the Koos Group had invested, to perform the first phase of human trials.
一直到 1997 年，陳垣崇透過現任辜公亮和信治癌中心醫院院長黃達夫引介，才獲得和信集團轉投資的 Synpac 藥廠贊助，進行第一階段的人體實驗。